Production (Stage)
Guardant Health, Inc.
GH
$38.00
$0.952.56%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -95.16M | -111.01M | -107.75M | -102.63M | -114.99M |
| Total Depreciation and Amortization | 10.24M | 10.45M | 10.60M | 10.62M | 10.71M |
| Total Amortization of Deferred Charges | -- | 646.00K | 645.00K | 645.00K | -- |
| Total Other Non-Cash Items | 45.57M | 38.23M | 57.65M | 51.06M | 66.12M |
| Change in Net Operating Assets | -23.34M | -2.83M | -12.20M | -53.70M | 7.87M |
| Cash from Operations | -62.69M | -64.51M | -51.06M | -94.00M | -30.28M |
| Capital Expenditure | -4.46M | -18.88M | -4.20M | -5.08M | -6.93M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 307.32M | 29.41M | -290.63M | 0.00 | 35.00M |
| Cash from Investing | 302.86M | 10.53M | -294.83M | -5.08M | 28.07M |
| Total Debt Issued | 5.03M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 768.00K | 5.03M | 20.00K | 9.58M | 213.00K |
| Repurchase of Common Stock | -60.51M | -8.02M | -2.87M | -3.24M | -1.54M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -12.14M | 59.00K | -31.00K | -438.00K | 257.00K |
| Cash from Financing | -66.85M | -2.94M | -2.89M | 5.90M | -1.07M |
| Foreign Exchange rate Adjustments | 773.00K | -1.70M | 1.90M | -837.00K | -1.14M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.10M | -58.61M | -346.87M | -94.02M | -4.43M |